ARDX vs CPT · rev $215.3M vs P/E 104, rev $5.3M
Ardelyx Inc (ARDX) versus Camden Property Trust (CPT) — a side-by-side from cached financials, not a winner call.
Ardelyx Inc (ARDX) is a biotechnology company listed on US.
Camden Property Trust (CPT) is a reit - residential company listed on US.
Latest reported ARDX revenue for 2026-06-30 was $215.3M. Net income was -$54.3M. ARDX currently screens at market cap $1.37B.
Latest reported CPT revenue for 2026-06-30 was $5.3M. Net income was $61.2M. CPT currently screens at market cap $12.11B and trailing P/E 104.0.
ARDX currently screens at market cap $1.37B. CPT currently screens at market cap $12.11B and trailing P/E 104.0.
Not investment advice. Open the ARDX and CPT stock pages for the full models.
Not investment advice.